While it may be possible to refrain from grinding and clenching while awake, some people do these things during sleep. You may wake up with sore jaws, a headache, toothache, jaw pain or face pain.
Without treatment, bruxism may lead to TMJ, cavities, tooth breakage and even tooth loss.
Our Bruxism Solution Program
Here at Ailesbury Clinic, we have helped many patients with our 3 Step Migraine Solution Program.
Muscle relaxant (or 'anti-wrinkle') injections can be used to successfully treat the condition, medically referred to as Bruxism.The treatments works by relaxing the masseter muscle and is the same technique used to reduce the squareness of the jawline.
1) Comprehensive Skin Consultation
Our knowledgeable and experienced team will take all detailed history of your symptoms to discover the intensity, frequency, triggers and discuss any previous treatment you may have tried.
2) Injection Therapy
We use BOTOX® as an alternative treatment for TMJ disorder and its associated jaw tension and pain.
When injected into afflicted facial muscles, BOTOX® for TMJ can relieve symptoms for many patients.
Injections often eliminate headaches resulting from teeth grinding, and, in cases of severe stress, BOTOX® can even minimise lock-jaw.
Areas targeted by TMJ Botox ® therapy
The injections are mainly in the temporalis, frontalis and masseter areas. Additional sites may be injected with Botox, depending on the severity of the pain.
Only the targeted areas injected with Botox will be “relaxed.” (Botox treatment for TMJ disorder will not affect other locations in your body.)
3) Breaking the cycle
Whether your goal is to be able to:
Get back to normal and feel like yourself again
Sleep through the night without waking with a migraine
Ongoing maintenance treatment is often recommended. Results can last up to 6 months.
The Science behind the Treatment
Bruxism and TMD
Over the past decade there has been an increase in the number of studies investigating the use of Botox A to treat TMD’s and bruxism with the dose range being on average from 35 to 200 U per side.
The muscles typically injected have been the masseter, the temporalis and the medial pterygoid which are the main muscles thought to be involved in bruxism.
It has been speculated that Botox A actually reduces bruxism by disrupting the trigeminal motor nucleus feedback loop and inhibits the central bruxism generator through mandibular muscle paralysis.
Alternatively, periodontal mechanoreptors during mastication may be deactivated by Btx-A which have a facilitatory effect on mandibular closure motor neurons.